A Rare Opportunity? NIH Program For Rare Diseases May Have Big Payoff For Drug Development

NIH Director Francis Collins is very excited about a $24 million program to de-risk small molecule treatments for rare disorders. You should be too.

Can a $24 million government program save drug development?

National Institutes of Health Director Francis Collins thinks one just might. The unlikely candidate? NIH's Therapeutics for Rare & Neglected...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet